Evidence map›Paper›PMID 24710170›Full record

ArticlePloS one2014

Biochemical properties and atomic resolution structure of a proteolytically processed β-mannanase from cellulolytic Streptomyces sp. SirexAA-E.

Taichi E Takasuka, Justin F Acheson, Christopher M Bianchetti, Ben M Prom, Lai F Bergeman, Adam J Book, Cameron R Currie, Brian G Fox

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.0field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Research and application progress of microbial β-mannanases: a mini-review.World journal of microbiology & biotechnology · 2024
    Review
  5. Comparative genomics of the niche-specific plant pathogenApplied and environmental microbiology · 2023
    Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Taichi E TakasukaGreat Lakes Bioenergy Research Center, University of Wisconsin -Madison, Madison, Wisconsin, United States of America; Department of Biochemistry, University of Wisconsin -Madison, Madison, Wisconsin, United States of America.
Justin F AchesonDepartment of Biochemistry, University of Wisconsin -Madison, Madison, Wisconsin, United States of America.
Christopher M BianchettiGreat Lakes Bioenergy Research Center, University of Wisconsin -Madison, Madison, Wisconsin, United States of America; Department of Biochemistry, University of Wisconsin -Madison, Madison, Wisconsin, United States of America.
Ben M PromGreat Lakes Bioenergy Research Center, University of Wisconsin -Madison, Madison, Wisconsin, United States of America.
Lai F BergemanGreat Lakes Bioenergy Research Center, University of Wisconsin -Madison, Madison, Wisconsin, United States of America; Department of Biochemistry, University of Wisconsin -Madison, Madison, Wisconsin, United States of America.
Adam J BookGreat Lakes Bioenergy Research Center, University of Wisconsin -Madison, Madison, Wisconsin, United States of America; Department of Bacteriology, University of Wisconsin -Madison, Madison, Wisconsin, United States of America.
Cameron R CurrieGreat Lakes Bioenergy Research Center, University of Wisconsin -Madison, Madison, Wisconsin, United States of America; Department of Bacteriology, University of Wisconsin -Madison, Madison, Wisconsin, United States of America.
Brian G FoxGreat Lakes Bioenergy Research Center, University of Wisconsin -Madison, Madison, Wisconsin, United States of America; Department of Biochemistry, University of Wisconsin -Madison, Madison, Wisconsin, United States of America.
Great Lakes Bioenergy Research Center · USUniversity of Wisconsin–Madison · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

β-Mannanase SACTE_2347 from cellulolytic Streptomyces sp. SirexAA-E is abundantly secreted into the culture medium during growth on cellulosic materials. The enzyme is composed of domains from the glycoside hydrolase family 5 (GH5), fibronectin type-III (Fn3), and carbohydrate binding module family 2 (CBM2). After secretion, the enzyme is proteolyzed into three different, catalytically active variants with masses of 53, 42 and 34 kDa corresponding to the intact protein, loss of the CBM2 domain, or loss of both the Fn3 and CBM2 domains. The three variants had identical N-termini starting with Ala51, and the positions of specific proteolytic reactions in the linker sequences separating the three domains were identified. To conduct biochemical and structural characterizations, the natural proteolytic variants were reproduced by cloning and heterologously expressed in Escherichia coli. Each SACTE_2347 variant hydrolyzed only β-1,4 mannosidic linkages, and also reacted with pure mannans containing partial galactosyl- and/or glucosyl substitutions. Examination of the X-ray crystal structure of the GH5 domain of SACTE_2347 suggests that two loops adjacent to the active site channel, which have differences in position and length relative to other closely related mannanases, play a role in producing the observed substrate selectivity.

Indexed as

Proteolysisbeta-MannosidaseCatalytic DomainCelluloseHydrolysisMannansModels, MolecularStreptomycesbeta-MannosidaseCelluloseMannans

Identifiers

PMID24710170
PMCPMC3978015
OpenAlexW2005238589

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.